PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK

Benzer Materyaller

• Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder
  Yazar:: Becker, W.C
  Baskı/Yayın Bilgisi: (2015)
• Predictors of dropout from inpatient opioid detoxification with buprenorphine. A chart review
  Yazar:: Hakansson, A.
  Baskı/Yayın Bilgisi: (2014)
• OPIOID DETOXIFICATION WITH BUPRENORPHINE, CLONIDINE, OR METHADONE IN HOSPITALIZED HEROIN-DEPENDENT PATIENTS WITH HIV INFECTION
  Yazar:: UMBRICHT, A.
  Baskı/Yayın Bilgisi: (2003)
• PREDICTORS OF BUPRENORPHINE NALOXONE DOSING IN A 12 WEEK TREATMENT TRIAL FOR OPIOID DEPENDENT YOUTH: SECONDARY ANALYSES FROM A NIDA CLINICAL TRIALS NETWORK STUDY
  Yazar:: CHAKRABARTI, A.
  Baskı/Yayın Bilgisi: (2010)
• EFFECTS OF BUPRENORPHINE AND NALOXONE IN MORPHINE-STABILIZED OPIOID ADDICTS
  Yazar:: FUDALA, P.J
  Baskı/Yayın Bilgisi: (1998)